The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Trachtenberg Eric since 2016.
This trader's CIK number is 1646300.
At the time of last reporting, Trachtenberg Eric was the SEE REMARKS of Kala Bio, Inc.. (stock ticker symbol KALA).
Also see all insider trading activities at Kala Bio, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | KALA | 0 | $0 | 1,227 | $8,269 | 0 | $0 |
2023 | KALA | 0 | $0 | 60 | $1,713 | 0 | $0 |
2022 | KALA | 0 | $0 | 5,463 | $4,671 | 0 | $0 |
2021 | KALA | 0 | $0 | 11,901 | $31,156 | 0 | $0 |
2020 | KALA | 0 | $0 | 0 | $0 | 28,901 | $149,996 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | ARLZ | 0 | $0 | 3,471 | $5,900 | 0 | $0 |
2017 | ARLZ | 0 | $0 | 7,720 | $10,267 | 0 | $0 |
2016 | ARLZ | 10,000 | $37,570 | 0 | $0 | 0 | $0 |
2. Aralez Pharmaceuticals Inc. (ARLZ)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-01-04 | KALA | Sale | 1,227 | 6.74 | 8,269 |
2023-01-04 | KALA | Sale | 60 | 28.55 | 1,713 |
2022-06-27 | KALA | Sale | 2,613 | .37 | 966 |
2022-01-04 | KALA | Sale | 2,850 | 1.30 | 3,705 |
2021-10-26 | KALA | Sale | 9,449 | 1.80 | 17,008 |
2021-06-28 | KALA | Sale | 2,452 | 5.77 | 14,148 |
2020-06-19 | KALA | Option Ex | 28,901 | 5.19 | 149,996 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-03-19 | ARLZ | Sale | 3,471 | 1.70 | 5,900 |
2017-06-23 | ARLZ | Sale | 7,720 | 1.33 | 10,267 |
2016-05-16 | ARLZ | Buy | 10,000 | 3.76 | 37,570 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Trachtenberg Eric (SEE REMARKS of Kala Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.